Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Phosphoproteomic Characterizat...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors

Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors

Bibliographic Details
Main Authors: David G. J. Cucchi, Carolien Van Alphen, Sonja Zweegman, Bo Van Kuijk, Zinia J. Kwidama, Adil al Hinai, Alexander A. Henneman, Jaco C. Knol, Sander R. Piersma, Thang V. Pham, Connie R. Jimenez, Jacqueline Cloos, Jeroen J. W. M. Janssen
Format: Article
Language:English
Published: Wolters Kluwer 2021-07-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000606
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://journals.lww.com/10.1097/HS9.0000000000000606

Similar Items

  • INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
    by: Robin Beekhof, et al.
    Published: (2019-04-01)
  • INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
    by: Robin Beekhof, et al.
    Published: (2019-05-01)
  • Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AML
    by: Anna Wojtuszkiewicz, et al.
    Published: (2021-08-01)
  • The clinical and biological consequences of different FLT3 mutations in patients with AML
    by: Mead, A. J.
    Published: (2009)
  • Inhibition of FLT3 expression by green tea catechins in FLT3 mutated-AML cells.
    by: Bui Thi Kim Ly, et al.
    Published: (2013-01-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...